Missing/wrong data?
Log in to edit
Randomised phase II trial of 4 dose levels of single agent docetaxel in performance status (PS) 2 patients with advanced non-small cell lung cancer (NSCLC): DOC PS2 trial. Manchester lung cancer group
scientific article
Author/s
author: Richard Wyn Griffiths, Raffaele Califano, Fiona Blackhall, Corinne Faivre-Finn, Paul Lorigan
Work details
Publication date
February 5, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.